Jingyang Li - Xiangya Medical College, Central South University

基本信息

浏览量：20

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 55 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Smart Pharmaceutical Monitoring System with Personalized Medication Schedules and Self-Management Programs for Patients with Diabetes: Development and Evaluation Study

Jian Xiao, Mengyao Li, Ruwen Cai, Hangxing Huang,Huimin Yu, Ling Huang,Jingyang Li, Ting Yu, Jiani Zhang,Shuqiao Cheng

Journal of medical Internet research (2025): e56737-e56737

引用0浏览0WOS引用

Targeting the Crosstalk Between Glutamine Metabolism and Tumor Immune Microenvironment for Lung Cancer Immunotherapy

Jingyang Li,Li Xiang, Shaohui Wang, Yingrui Zhang, Shiyi Zhao, Di Zhang,Xianli Meng,Yi Zhang,Jin‐Ming Lin

Interdisciplinary Medicineno. 2 (2025): n/a-n/a

引用0浏览0引用

Peficitinib Suppresses Diffuse-Type Tenosynovial Giant Cell Tumor by Targeting TYK2 and JAK/STAT Signaling

Shan Lu,Chenxi Cao, Wenjia Zhang,Jiayi Li,Jingli Yang, Zisheng Huang, Zhijun Wu, Baitao Liu,Hongjie Huang, Haijun Wang, Yongjian Wang,Dingge Liu, Zhihua Zhang, Kaiping Liu, Gang Yang, Xi Gong, Hui Dai, Yingjia Li,Erdan Dong,Xin Zhang,Yan Zhang

Science China Life Sciencespp.1-17, (2025)

引用0浏览0WOS引用

Data - Knowledge Driven Machine Learning Model for Cancer Pain Medication Decisions

Lu Zhang,Hui-Min Yu,Jing-Yang Li, Ling Huang,Shu-Qiao Cheng,Jian Xiao

INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS (2025)

引用0浏览0WOSEI引用

Risk of Acute Renal Failure Associated with Combined Use of SGLT2 Inhibitors and Potentially Nephrotoxic Drugs: an Epidemiological Surveillance Study Based on the FDA Adverse Event Reporting System (FAERS)

Ting Yu,Jian Xiao, Mengyao Li,Shu Qiao Cheng, Ruwen Cai, Ling Huang,Huimin Yu,Jing Yang Li, Ying-Ying Zhang, Ying Wang

Expert opinion on drug safetypp.1-12, (2025)

引用0浏览0WOS引用

Efficacy of Ixekizumab in Chinese Patients with Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level

Ning Kong, Jiankang Hu,Dongzhou Liu,Jingyang Li,Huaxiang Wu,Lingyun Sun,Dai Lie,Chunyu Tan,Zhijun Li,Zhengyu Xiao,Cibo Huang,Jian Xu, Yan, Hongying Li,Hejian Zou

Rheumatology and therapy (2025)

引用0浏览0WOS引用

Identify Drug-Drug Interactions Via Deep Learning:A Real World Study

Jingyang Li, Yanpeng Zhao, Zhenting Wang, Chunyue Lei, Lianlian Wu,Yixin Zhang, Song He,Xiaochen Bo,Jian Xiao

Journal of Pharmaceutical Analysispp.101194, (2025)

引用0浏览0引用

Ixekizumab for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 52-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study

Yu Xue,Jiankang Hu,Dongzhou Liu,Jingyang Li,Huaxiang Wu,Chunyu Tan,Lie Dai,Lingyun Sun,Zhijun Li,Zhengyu Xiao,Cibo Huang, Yan,Fei Ji, Rong Chen,Hejian Zou

BIODRUGS（2024）

引用1浏览0WOS引用

Vunakizumab in Patients with Active Psoriatic Arthritis: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study

Hejian Zou,Weiguo Wan,Yu Xue,Lingyun Sun, Ning Zhang, Haiying Chen,Xiaofei Shi,Shengyun Liu, Lin Chen,Xinmei Ma,Hua Wei,Zhenyu Jiang,Xiaomei Li, Hongtao Fan, Hongbin Li,Jingyang Li,Rui Wu,Guixiu Shi, Jing Zhu,Xiaodan Kong,Yuewu Lu, Xiaojing Cui, Qianning Zheng, Xiaoyan Bai, Guangchao Dong

ARTHRITIS & RHEUMATOLOGY (2024): 5240-5242

引用0浏览0引用

Optimizing Medication Guidance Support for Patients with Cancer Pain: Development and Evaluation of a Pharmaceutical Care System for Healthcare Professionals

Ling Huang,Lu Zhang,Hangxing Huang, Ruwen Cai,Huimin Yu,Jingyang Li, Mengyao Li, Ting Yu,Shuqiao Cheng,Jian Xiao

Supportive Care in Cancerno. 8 (2024): 1-12

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn